| East Bay Getting to Zero and California Prevention Training Center PrEP Learning Collaborative held an update on Lenacapavir for PrEP on Thursday, June 26, 2025. This session was the first in a three-part series focusing on Lenacapavir as injectable, long-acting PrEP. What: Injectable PrEP Update: Lenacapavir as PrEP Who: Jessica Bloome, MD, MPH, University of California at San Francisco, San Francisco Department of Public Health Slides: Included below Watch for the announcement of sessions 2 and 3, which will focus on clinical implementation, navigation, and patient access and assistance. If you did attend the session, please complete our feedback form – your input will assist us in planning future sessions. Additional resources: – Gilead has scheduled three information sessions on Lenacapavir/Yeztugo. You can register here. You can find additional information on Yeztugo here. |
